Omnicare, a subsidiary of CVS Health, entered into an asset purchase agreement with GenieRx Holdings as part of its ongoing court-supervised sale process.
- GenieRx to serve as the “stalking horse bidder,” setting the floor for the sale of the company’s assets
- GenieRx is a joint partnership between Milrose Capital and Integro Asset Management
- Deadline for competing bids is April 30
- Auction expected on May 5 if qualified bids are received
- NOTE, Dec. 3: Omnicare Approved to Move Forward With Bankruptcy Sale Process
To view the source of this information, click
To contact the reporter on this story:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
